Use
Treatment of chronic lymphocytic leukemia (CLL) for patients who did not respond to alkylating agents
Features
First treatment in a new class of highly effective chemotherapy agents (the purine analogues) for chronic lymphocytic leukemia
NIH Contribution
Synthesis and use of fludarabine for cancer